Lv11
60 积分 2023-11-29 加入
Potent and Selective RIPK1 Inhibitors Targeting Dual‐Pockets for the Treatment of Systemic Inflammatory Response Syndrome and Sepsis
16天前
已完结
Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials
2个月前
已完结
Ozanimod for Ulcerative Colitis
2个月前
已完结
Ulcerative Colitis in Adults
2个月前
已完结
P038 Ozanimod First-Dose Cardiac Effects in Patients with Moderately to Severely Active Ulcerative Colitis and Relapsing Multiple Sclerosis
2个月前
已完结
Progress report on new medications for seizures and epilepsy: A summary of the 17th Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVII). I. Drugs in preclinical and early clinical development
3个月前
已完结
Development of a novel bispecific antibody GR1801 for rabies
3个月前
已完结
Etrasimod for the treatment of ulcerative colitis
3个月前
已完结
Proinflammatory phenotype in major depressive disorder with adulthood adversity: In line with social signal transduction theory of depression
7个月前
已完结
The Potential of KCNQ Potassium Channel Openers as Novel Antidepressants
7个月前
已完结
皖公网安备34019202002308
